Search
Showing results for "lung disease preterm"
Nirsevimab is an extended half-life monoclonal antibody to the respiratory syncytial virus (RSV) fusion protein that has been developed to protect infants for an entire RSV season. Previous studies have shown that the nirsevimab binding site is highly conserved. However, investigations of the geotemporal evolution of potential escape variants in recent (ie, 2015–2021) RSV seasons have been minimal.
Staphylococcus epidermidis is a nosocomial pathogen that causes catheter-associated bacteremia in the immunocompromised, including those at the extremes of age
We are studying exercise in young people with T2DM and obese young people at risk of developing type 2 diabetes
Investigating the effect of fat and protein content of a standardised carbohydrate meal on the post-prandial glycaemic response in children with type 1 diabetes
The main aim of our Leukaemia Translational Research Team is to test innovative therapeutic approaches, with a focus on clinical translation of this knowledge, to improve the outcomes of children suffering from leukaemia.
What role will you play in creating a brighter and healthier future for our kids?
research assistant genetics and rate diseases
PhD Student - Clinical Epigenetics
The Opportunity: Vaccine Trials Group are looking for two Research Nurses to work in our vibrant team. The Research Nurses will work alongside the
Employment Opportunity: Development Officer (administration)